DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

Go back to DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

DiaMedica Therapeutics Inc. (DMAC) Reports Q3 Loss of $0.20/Share

November 13, 2019 4:23 PM EST

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.20), versus ($0.18) reported last year.

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

... More